EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASE
- 1 May 1980
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 315 (8177), 1043-1047
- https://doi.org/10.1016/s0140-6736(80)91496-8
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONEThe Lancet, 1979
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Sodium Etidronate in the Treatment of Paget's Disease of BoneAnnals of Internal Medicine, 1977
- Diphosphonate Therapy of Paget's Disease of BoneJournal of Clinical Endocrinology & Metabolism, 1977
- PAGET'S BONE DISEASE TREATED WITH DIPHOSPHONATE AND CALCITONINThe Lancet, 1976
- DIPHOSPHONATES IN PAGET'S DISEASEThe Lancet, 1974
- Effect of a Diphosphonate on Para-Articular Ossification after total Hip ReplacementActa Orthopaedica, 1974
- Influence of Disodium Etidronate on Clinical and Laboratory Manifestations of Paget's Disease of Bone (Osteitis Deformans)New England Journal of Medicine, 1973
- The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatitein vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised ratsCalcified Tissue International, 1970
- Diphosphonates Inhibit Formation of Calcium Phosphate Crystals in vitro and Pathological Calcification in vivoScience, 1969